Lake Point Wealth Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
DSA
Lake Point Wealth Management's DGX Position: Q2 2022 in Review
Lake Point Wealth Management sold out of Quest Diagnostics (DGX) in Q2 2022, closing a stake of 47 shares — an estimated $6K sold.
Lake Point Wealth Management first reported a position in DGX in Q4 2021 and held it in 2 quarters. The position peaked at $8K in Q4 2021. 851 funds tracked by Wall St. Rank hold DGX as of Q2 2022.
- Lake Point Wealth Management reported no remaining Quest Diagnostics position as of Q2 2022 after selling out during the quarter.
- Lake Point Wealth Management sold 47 Quest Diagnostics shares in Q2 2022, an estimated $6K.
- Lake Point Wealth Management first reported a position in Quest Diagnostics in Q4 2021 and held it in 2 quarters.
- Lake Point Wealth Management's Quest Diagnostics position peaked at $8K in Q4 2021.
- 851 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2022.
Based on Lake Point Wealth Management's 13F filing for Q2 2022, filed 19 Jul 2022.